
Erlotinib 100 mg (Erlocip) is a targeted anticancer medicine used to treat certain types of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by blocking the epidermal growth factor receptor (EGFR), a protein that helps cancer cells grow and divide. By inhibiting EGFR, Erlotinib helps slow or stop the growth and spread of cancer cells.
| Generic name | Erlotinib |
| Strength | 100 mg |
| Manufacturer | CIPLA |
| Package size | 30 Tablets |
| Used for | Non-small cell lung cancer (NSCLC) and pancreatic cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Erlotinib is an EGFR (epidermal growth factor receptor) inhibitor. It blocks the EGFR protein, preventing cancer cells from receiving signals needed for growth and division. This slows the growth and spread of cancer cells while helping control the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.